CPHI Online is the largest global marketplace in the pharma ingredients industry

  • Products
    0
  • Companies
    0
  • Articles
    0
  • Events
    0
  • Webinars
    0

Enerceptant / Etanercept 25mg /50mg PFS

Enerceptant / Etanercept 25mg /50mg PFS
Product Description

Etanercept 25 mg / 0,5ml PFS & Etanercept 50 mg / 1,0 ml with autoinjector

AMEGA Biotech

  • AR
  • 2019
    On CPHI since
  • 2
    Certificates
  • 250 - 499
    Employees
Company types
Manufacturer/Innovator
Primary activities
Biopharmaceutical
Specifications
  • Details
    For Subcutaneous AdministrationIn rheumatoid arthritis:
    Substantial improvement in signs and symptoms,
    Effective in monotherapy and combination therapy,
    Well-tolerated treatement.
  • Supplied from
    Argentina
  • Measured In
    piece

AMEGA Biotech

  • AR
  • 2019
    On CPHI since
  • 2
    Certificates
  • 250 - 499
    Employees
Company types
Manufacturer/Innovator
Primary activities
Biopharmaceutical

More Products from AMEGA Biotech (2)

AMEGA Biotech resources (1)

Recommended Products

  • Product Feronsure

    Interferon alpha 2a 3 MIU/0.5 ml
  • Product Heparin-Indar

    Prjsc "Indar" provides wide range of antithrombotic products which includes heparin-indar. The product of direct anticoagulant group. Heparin acts fast. Is applied for treatment of thrombembolia and diseases that have risk of thromboembolic complications, for prevention of post surgery venous thrombosis an...
  • Product Biologics

    End-to-end development and manufacturing capabilities across different therapeutic modalities and the entire product lifecycle

    Cutting-edge technology platforms for high yielding cell lines (both mammalian and microbial) and high concentration formulations


    Integrated and flexible drug sub...
  • Product Eylea biosimilar vial & PFS

    1.Completion of global clinical trials phase Ⅲ 
    2. Completion of pre-submission meetings with advanced regulatory authorities
    3. Available in Vial and PFS
  • Product Romiplostim Biosimilar Candidate

    Due to the complex nature of the product, Paras Biopharmaceuticals has been intensively working on this complex drug (Nplate™) for over 6 years and has progressively achieved success. The company plans to mature good value within its Romiplostim asset (Biosimilar) and would like to highlight the following...
  • Product Pharmaceutical and Biological Products Contract Development and Manufact...

    Bora Pharmaceuticals is a premier international contract development and manufacturing organization (CDMO). Our six state-of-the-art cGMP manufacturing facilities across Asia and North America deliver to more than 100 markets around the world. Our sites have the highest industry standards for quality, dev...
  • Product HANLIKANG (Rituximab Injection)

    HANLIKANG (rituximab injection) is the company's first proprietary product. It is the first-ever China-manufactured biosimilar approved by the NMPA in accordance with the Technical Guideline for the Development and Evaluation of Biosimilars (Tentative) issued in 2015. As of now, HANLIKANG has bee...
  • Product Interview by Newsweek, time to talk

    Interviewee:Dr. Steve J.P. Hsu (President of Genovior Biotech)
  • Product Truxima

    • Ingredient: Rituximab • Indication: Non-Hodgkin's lymphoma, rheumatoid arthritis • Mode of mechanism: Specifically binds to CD20, which is expressed on the cell surface of human B cells and lyses target cells to express pharmacological action with mechamisms such as complement-dependent cytotoxicity, ...
  • Product Pipeline

    Polpharma Biologics has its own pipeline of biosimilars for out-licensing.
    We are focused on advancing and expanding our product portfolio to increase patient access to these much-needed therapies and are open to partnering with other organizations to co-develop or commercialize our biosimilars.
  • Product Biologic drug substance CDMO services

    From pre-clinical development to commercial supply, Patheon by Thermo Fisher Scientific is an industry leader in the development and manufacture of mammalian cell culture drug substances. Patheon offers biotech and pharmaceutical companies the ability to pursue opportunities around the globe with a fully i...
  • Product Biosimilars

    Portfolio of high-producing biosimilar cell lines and processes, off-the-shelf and generation of such from scratch. Biosimilarity optimisation of your recombinant cell line. Your benefit: Cost and time-savings, while bringing your product to the market. https://excellgene.com/offerings/biosimilars/
  • Product Elizaria® (eculizumab)

    Paroxysmal nocturnal hemoglobinuria + atypical hemolytic uremic syndrome

  • Product Mipeginterferon alfa-2b

    Pegylated human interferon alfa-2b

    Trade name: PEGBING

    Technology
    Recombinant gene technology, expressed by Yeast

    Amino acid
    165 amino acids

    Molecular weight
    Approximately 59 kD

    Indications
    Chronic hepatitis B & C

    ...
  • Product Walk in Cooling Cabinet.

    The Walk-In Cooling Cabinets / cold rooms are designed according to ICH guidelines, WHO, MCA and USFDA requirements to maintain uniform conditions. They are superior in airflow distribution, temperature control technology, cabinet construction and are manufactured as per cGMP regulations.
    Biggest Walk...
  • Product Biomedtracker

    Biomedtracker provides real-time analysis of major market-moving events in the pharma and biotech industries. With catalyst tracking and expert insights, Biomedtracker helps you stay on top of breaking events, the drugs pipeline, upcoming milestones, companies, and deals – and their impact on the marke...
  • Product Humodar C25 100R

    PRJSC 'Indar' provides wide range of insulin products in vials and cartridges which includes humodar c25 100r. Its an anti-diabetic product of short effect. Ensures quick decrease of glucose level in the blood, intensifies its absorption by tissues. The effect starts after 30 minutes and can last within 5-...
  • Product Humodar B 100R

    PRJSC 'Indar' provides wide range of insulin products in vials and cartridges which includes humodar b 100r. Its an anti-diabetic product of short effect. Ensures quick decrease of glucose level in the blood, intensifies its absorption by tissues. The effect starts after 30 minutes and can last within 5-7 ...
  • Product INJECTABLES

    Requiring injectables.EU-GMP is a must.
    EU dossier is a must.
    Licensing and supply model or distributorship.
  • Product UV Light Blocking Tyvek Equipment Covers

    UV Light Blocking Tyvek Equipment Covers are designed to keep cleaned pharmaceutical equipment and supplies clean and protected from external sources of contamination while also providing in-process protection to light sensitive biotech products.
  • Product Biomarker Assays and Validation

    Validation of biomarker assays: Our diverse range of analytical platforms supports biomarker analyses including ELISA, flow cytometry, cell-based assays, multiplex ECL platforms, and high sensitivity measurements using QuanterixSimoa HD-X Analyzer™ measurement instruments. Our dedicated biomarker assay...
  • Product Biosimilars Portfolio

    • Pegfilgrastim (Filed with EMA) • Filgrastim (Filed with EMA) • Trastuzumab (Filed with EMA, MHRA, Received recommendation for marketing authorization in India) • Bevacizumab (Filed with MHRA) • Omalizumab (Global PhIII ongoing) • Denosumab (Global PhIII ongoing) • Ranibizumab (Global PhIII ongoing...
  • Product Biologic Quality Control and Release Testing

    We deliver responsive QC analysis for complex biologic products from our cGMP laboratories. Our scientists develop and validate methods or perform technology transfer of a sponsor's method for a wide range of analytical methods required for batch release testing. We also routinely carry out testing to Phar...
  • Product Cell line development services

    Cell line development services, including molecular cloning, CHO cell line development and lead clone selection, bioprocess optimization, DSP and analytical characterization of the target molecule.



  • Product EPOMAX 2000 (RECOMBINANT HUMAN ERYTHROPOEITIN ALPHA? 2000 UI / 1 ml)

    After granting the Marketing Authorization of THE FIRST Human Recombinant alpha Erythropoietin (EPO), MédiS becomes the FIRST Tunisian pharmaceutical company to produce and market its biosimilar EPO commercially appointed as EPOMAX®.

  • Product Yuflyma

    • Ingredient: Adalimumab • Indication: Rheumatoid arthritis, inflammatory bowel disease • Mode of mechanism: Blocks the transmission of inflammatory signals by binding to TNF-α in the body   • Approval status: 44 countries including the US(product name: Inflectra), Europe and South Korea 
  • Product Recombinant human erythropoietin injection (cho cell)

    Shandong kexing bioproducts offers a wide range of products which includes recombinant human erythropoietin injection (cho cell). It is colorless and transparent liquid with ph6.9±0.5. Packaging: pre-filled syringe or vial. Storage: stored at 2-8?. Contact us for more information.

  • Product Technology Transfer-Biosimilars

    "If you're interested in Tech Transfer projects, our team is well-prepared to assist you with Biosimilar products such as Insulin or Monoclonal Antibodies. We have a network of over 10,000 partners who are willing to explore these opportunities. Please don't hesitate to reach out for more information on th...
  • Product Post-translational modifications

    Intertek offers wide range of pharmaceutical services which includes post-translational modifications. It belongs to biopharmaceutical protein analysis services category. It includes deamidation, glycosylation, glycylation, phosphorylation, acetylation , alkylation, sulfation, etc.
  • Product Kemwell Biopharma

    SERVICES Kemwell provides integrated development and manufacturing services for companies that require one-stop solution for mammalian cell-culture based protein therapeutics The team is experienced to undertake end-to-end activities right from cell line development till cGMP clinical and commercial manufa...
  • Product Comparability Studies for Biopharmaceuticals

    We design bespoke analytical programmes that ensure that the relevant quality attributes for your drug substance or product are evaluated to support your manufacturing process changes. We select analytics referenced by the ICH Q6B to examine the product's structural features (primary, secondary and&nb...
  • Product Leuprolide 3-Month Implant

    The active ingredient leuprorelin, like goserelin, is a synthetic peptide that can be used primarily in the treatment of hormone-dependent tumors, particularly prostate cancer. Administration of leuprorelin has indirect effects on testosterone levels in men, the lowering of which stops the growth of malign...
  • Product Biotechnology Services

    Midas Pharma offers a wide range of pharmaceutical services which include biotechnology services. It offers:  • development of biosimilars and proprietary biologicals (starting from gene sequence) • cGMP production (microbial and mammalian cells) • related bioanalytics (from protein biochemical meth...
  • Product RinLis® Mix 25

    Insulin lispro biphasic 25.Dosage form: susupension for subcutaneous injections in 3 ml cartridges and pre-filled disposable insulin pen.

    ·         Has fast and predictable effect and the elimination typical for physiologic insulin secretion.
    ·...
  • Product Remsima

    The world's 1st mAb biosimilar • Ingredient: Infliximab • Indication: Rheumatoid arthritis, inflammatory bowel disease • Mode of mechanism: Relieves disease progression by inducing a neutralizing response to tumor necrosis factor(TNF-α), the cause of autoimmune disease • Approval status: 100 countri...
  • Product Epokine Inj. (rh-EPO)

    Anemia of hemodialysis patients with end-stage renal disease
  • Product Monomaterial Packaging Specialist

    Pharma and Biotech toploading and sideloading cartoning systems from the monomaterial specialistDividella from Switzerland provides pharma and biotech packaging systems for the secondary packaging of parenterals. Dividella's patented top-loading and recently also side-loading cartoners package syringes, vi...
  • Product Anakinra Biosimilar Candidate

    Paras Biopharmaceuticals has been intensively working on a Anakinra / IL1-RA biosimilar known as Kineret™) and has progressively achieved success. The company plans to mature good value within its Anakrina / IL1-RA asset and would like to highlight the following points / highlights to gauge your level of ...
  • Product Sterile Grade at ISO Class 5 facility

    Kikkoman can offer "sterile grade” products, purified through a super purification process at our ISO Class 5 facility, approved by the Japanese Authority. 
  • Product HANBEITAI (Bevacizumab Injection)

    HANBEITAI (generic name: bevacizumab), the fourth product independently developed by Henlius, received marketing approval from the National Medical Products Administration (NMPA) in November 2021, and its commercialization in Chinese mainland is handled by the company's in-house team. As of now, HANBEI...
  • Product Method Development

    We are specialist in the method development of analytical methods for analysis of API, Final Drug Products or low level impurities. Usually followed by full validation in accordance to ICH guidelines.
  • Product Custom Protein Synthesis

    We provide a Custom Protein Synthesis Service, using a chemical method that synthesises proteins amino acid by amino acid and making modifications on an atomic-scale. We work closely with our partners in designing, customising and optimising the proteins that is synthesized in an automa...
  • Product RARE DISEASES & ORPHAN DRUGS

    Lodaat has a portfolio pipeline of Rare Disease and Orphan Drug products.  USFDA in development, we are looking for partners for the US, GCC, LATAM, EU markets.  Many products are made in USA products in FDA approved facilities.
  • Product Protein Therapeutic Glycosylation Studies

    In line with ICH Q6B, we deliver glycosylation analysis for proteins, antibodies, bispecifics including assessment of the glycosylation site, carbohydrate content and glycan structure. With a range of MS approaches, our protein characterisation scientists provide detailed glycosylation studies designed to ...
  • Product Herzuma

    • Ingredient: Trastuzumab • Indication: Breast cancer, stomach cancer • Mode of mechanism: Inhibits tumor cell proliferation and growth by binding to a specific antigen (HER2) that occurs specifically and excessively on the surface of tumor cells  • Approval status: 80 countries including US, Euro...
  • Product Gamma Irradiated Cleanroom Facemasks With Tyvek Side Extensions

    Gamma Irradiated, Extra Large Cleanroom Facemask with Tyvek® Side Extensions, Green or Blue, with Double Elastic Headbands and with or without Fog-Prevention Adhesive are made from an inner facing of soft cellulose material, an outer facing of spunbonded polypropylene and a 100% meltblown polypropylene med...
  • Product Rituximab

    Rituximab binds itself to the CD20 protein, marking them, and subsequently triggering the cells of the immune system to pick out the marked cells and kill them.The indication is for Non Hodgkin Lymphoma